Clifford Chance has advised Fresenius Kabi on the sale of its subsidiary Laboratorio Sanderson S.A. in Chile to Medifarma.
Laboratorio Sanderson S.A. holds a manufacturing plant of injectable products and other liquid substances for medical applications in Santiago de Chile. Medifarma, a multinational pharmaceutical company from Peru with a strong presence in Latin America, will continue the manufacturing of the existing portfolio of products in Chile.
The Clifford Chance team advising Fresenius Kabi was led by partner Javier Amantegui, together with senior associate Beatriz Melo and associate Andreína Velásquez and supported by associate Sofía Albiñana.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
